ConductScience.org, home

Library / Trials

A Randomized Controlled SaCo-VLM Trial

NCT07922746, Not applicable, Not yet recruiting, University of Malaya

Trial 10

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

FieldValueSource
TitleA Randomized Controlled SaCo-VLM TrialClinicalTrials.gov
NCT numberNCT07922746ClinicalTrials.gov
StatusNot yet recruitingClinicalTrials.gov
PhasesNot applicableClinicalTrials.gov
Enrollment70 participants, estimatedClinicalTrials.gov
Lead sponsorUniversity of MalayaClinicalTrials.gov
ConditionsGeneral Anaesthesia Using Supraglotic AirwayClinicalTrials.gov
InterventionsVideo-adjusted SaCoVLM insertion, Conventional blind SaCoVLM insertionClinicalTrials.gov
First posted2026-11-06ClinicalTrials.gov
Last updated2026-11-06ClinicalTrials.gov

Registered outcomes 5

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescriptionSource
PrimaryIncidence of Distorted Glottic View Following Head and Neck RepositioningIntraoperatively, immediately following successful SaCoVLM insertion, during assessment in four standardised head and neck positions (approximately 5-10 minutes after insertion).
The proportion of participants with a distorted glottic view (SaCoVLM Grade 1 or 2) following head and neck repositioning, despite satisfactory conventional airway placement tests. Glottic views will be assessed using recorded SaCoVLM images in three repositioned states: 45° lateral rotation, 45° neck extension, and 30° neck flexion, with neutral supine position as the reference. The incidence will be compared between video-adjusted and conventional blind insertion groups. Grades 1-2 indicate partial visualisation of the laryngeal inlet, whereas Grades 3-4 indicate satisfactory glottic visualisation.
ClinicalTrials.gov
SecondaryOropharyngeal Leak Pressure Across Head and Neck PositionsIntraoperatively, during the four head and neck positioning assessments immediately following successful insertion.
Oropharyngeal leak pressure (OLP), measured in cmH2O, will be assessed in four standardised head and neck positions: neutral supine, 45° lateral rotation, 45° neck extension, and 30° neck flexion. OLP will be measured using the adjustable pressure-limiting valve technique. Measurements will be compared between the video-adjusted and conventional blind insertion groups to evaluate airway seal performance during repositioning.
ClinicalTrials.gov
SecondaryTime Required for SaCoVLM InsertionDuring initial SaCoVLM insertion under general anaesthesia.
Time in seconds required to achieve confirmed SaCoVLM placement. Confirmation is defined as achieving an optimal glottic view in the video-adjusted group or meeting conventional airway placement criteria in the blind insertion group. Insertion times will be compared between groups to evaluate procedural efficiency.
ClinicalTrials.gov
SecondaryNumber of SaCoVLM Insertion AttemptsDuring initial SaCoVLM insertion under general anaesthesia.
Number of attempts required to achieve successful SaCoVLM placement, recorded for each participant. The number of insertion attempts will be compared between the video-adjusted and conventional blind insertion groups to assess insertion efficiency.
ClinicalTrials.gov
SecondaryAnaesthetist-Rated Ease of SaCoVLM InsertionImmediately following SaCoVLM insertion.
Ease of SaCoVLM insertion will be assessed by the inserting anaesthetist using a numerical rating scale (NRS). Ratings will be compared between the video-adjusted and conventional blind insertion groups to evaluate perceived procedural difficulty.
ClinicalTrials.gov

Outcomes 0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

TypeOutcomeTime framePopulationUnitsMeasured asSource

Results by group 0

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnitsSource

Participant flow 0

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits countedSource

Adverse events 0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEventsSource

Adverse event totals 0

The totals the trial posted for each group.

TotalGroupAffectedAt riskSource

Papers 0

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource

Grants 0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

ProjectTitlePrincipal investigatorsOrganizationFunderFiscal yearsSource

Trial comparisons 0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

ComparisonSource

Tests 0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

TestNamed asSource

Source 5

FieldValueSource
Releasetrials-2026-11-12-0.4.0ClinicalTrials.gov
Release manifest SHA-2560f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4ClinicalTrials.gov
Registry capture2026-11-12ClinicalTrials.gov
Results copy, AACT2026-03-23ClinicalTrials.gov
NIH clinical studies file2026-11-13ClinicalTrials.gov

The same record as JSON

Release trials-2026-11-12-0.4.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)